制度・支援
指定難病 — No.341

TRPV4異常症

検索語 TRPV4-Related Disorders ・ 最終更新 2026-07-21 17:32 ・ 最新に更新

Data Sheet
指定 No.341
Src PubMed · CT.gov · jRCT

これは医療アドバイスではありません。診断・治療の判断は必ず主治医にご相談ください。論文や治験は「今わかっている研究の状況」を示すもので、効果を保証するものではありません。

( 01 )EVIDENCE / PUBMED · 4件

世界の論文

直近の研究を、やさしい日本語で

各論文の見出しにある「確からしさ」は、その研究がどれくらい信頼できるかの目安です。「理論段階」はまだ仮説に近く、下にいくほど多くの患者で検証されていて、「メタ解析」がもっとも信頼できます。

基礎研究(細胞・動物など)
MK-01 · PMID 41843287

Mechanobiological Response of Osteocyte TRPV4 Base on the Piezoelectricity of Bone Matrix

Abstract / 原文

PURPOSE: Osteocytes are force-sensitive cells possessing a complex lacunar-canalicular system (LCS), embedded within a piezoelectric bone matrix. TRPV4, as a key mechanosensor, plays a crucial role in osteocyte mechanotransduction and related bone disorders. However, the mechanisms underlying its force sensing, mechanical signaling pathways, and biomechanical response remain poorly understood. METHODS: To address this issue, this study established a finite element model incorporating multiple mechanosensors-including bone matrix, LCS, osteocytes, and TRPV4-based on the piezoelectric effect. By integrating the multiphysics coupling of solid mechanics, fluid mechanics, and electric fields to simulate the complex effects on osteocytes, the model calculated stress, strain, and fluid shear stress (FSS) on TRPV4. RESULTS: Result indicate that piezoelectricity significantly increases stress and strain in TRPV4, particularly FSS. Biomechanical parameters of TRPV4 exhibit significant variations across different locations, with the highest stress levels observed at the cell processes (Maximum increase of approximately 300%). Stress distribution patterns also differ across distinct regions, while stress concentration in TRPV4 primarily occurs in its transmembrane domain and ion channel regions. This study reveals that upon coupling with primary cilia and RhoA, the mechanical response mechanism of TRPV4 undergoes significant alteration. TRPV4 exhibits greater sensitivity to fluid shear stress, whereas Piezo1 responds more strongly to membrane stress. CONCLUSIONS: This study elucidates the microscopic mechanical response mechanism and gating activation mechanism of TRPV4 within complex bone cell environments. It clarifies the interaction mechanisms between TRPV4 and other cellular structures, providing a research pathway for understanding bone cell mechanical transduction mechanisms and complex interactions across multiple scales. This work offers theoretical insights into the pathogenesis and therapeutic approaches for TRPV4-related bone disorders.

Journal
Annals of biomedical engineering(2026 Mar)
Authors
11名
Type
Journal Article
PubMedで原文を見る
観察研究
MK-02 · PMID 41263626

Expanding the Genotype and Phenotype Diversity in a Chinese Cohort With TRPV4-Related Dysplasia

Abstract / 原文

Dominant mutations in the calcium permeable ion channel TRPV4 (transient receptor potential vanilloid 4) typically result in skeletal dysplasia or peripheral neuromuscular disease. However, the full spectrum of TRPV4-related phenotypes remains incompletely defined. This study systematically reviewed the clinical and genetic features of 10 Chinese patients harboring various TRPV4 variants. In the cohort, six patients were diagnosed with spondylometaphyseal dysplasia Kozlowski type (SMDK) and four patients with metatropic dysplasia (MD). The most common features involved spinal deformity (platyspondyly, kyphosis or scoliosis), and lower-limb malalignments (genu varum, genu valgum, or leg-length discrepancy). Two patients with MD had neurological deficits. The R594H and P799R substitutions were the most recurrent variants in our study. A novel variant (c.1628T>G, p.L543R) in the S2-S3 loop was identified. The study seeks to improve diagnostic precision by combining genetic and radiographic assessment, and highlights the importance of early spinal surveillance and multidisciplinary care to prevent neurological complications underlying TRPV4-mediated disorders.

Journal
Clinical genetics(2026 Apr)
Authors
9名
Type
Journal Article
PubMedで原文を見る
症例報告
MK-03 · PMID 41225599

A novel TRPV4 variant in spondylometaphyseal dysplasia, kozlowski type reveals a previously unreported loss-of-function mechanism

Abstract / 原文

Spondylometaphyseal Dysplasia, Kozlowski Type (SMDK) is an autosomal dominant skeletal disorder characterized by marked scoliosis, platyspondyly, overfaced pedicles, and mild metaphyseal changes. Pathogenic variants in TRPV4, which encodes a calcium-permeable nonselective cation channel, are known to underlie SMDK. In this study, we identified a previously unreported missense variant in NM_021625.5(TRPV4): c.2354G > C (p.Trp785Ser), in a patient clinically diagnosed with SMDK. This variant affects a highly conserved residue and is predicted to alter protein conformation. Functional validation through cellular experiments revealed that the p.W785S substitution markedly reduces agonist-induced calcium influx and membrane currents, indicating a loss-of-function effect on TRPV4 channel activity. This deviates from the typical gain-of-function paradigm observed in most TRPV4-related skeletal dysplasias and may explain the relatively milder phenotype in our case. Our findings establish p.W785S as a novel pathogenic variant and highlight loss of TRPV4 activity as an alternative mechanism contributing to disease pathogenesis in SMDK.

Journal
Orphanet journal of rare diseases(2025 Nov)
Authors
6名
Type
Journal Article, Case Reports
PubMedで原文を見る
症例報告
MK-04 · PMID 41199732

The case of a highly trained TRPV4 related scapuloperoneal spinal muscular atrophy patient: a 5-year follow-up

Abstract / 原文

OBJECTIVES: This case report explores the feasibility and effects of long-term physical exercise (PE) in a patient with TRPV4-related scapuloperoneal spinal muscular atrophy (SPSMA). METHODS: We describe a 26-year-old male who regularly engaged in supervised PE since age 21. He underwent annual clinical evaluations and laboratory assessments every 25 months to monitor maximal oxygen consumption (V̇O2max), muscle strength, body composition, and emotional well-being. RESULTS: Over five years, the clinical condition remained stable. The patient showed V̇O2max and handgrip strength values comparable to athletic cohorts; body composition aligned with reference values for age- and sex-matched healthy individuals; and limb muscle strength was preserved over time. Additionally, he maintained an active working life and consistently reported positive emotional well-being throughout the follow-up period. CONCLUSIONS: This report provides preliminary data supporting the feasibility and potential benefits of long-term PE in the management of TRPV4-related SPSMA.

Journal
Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology(2025 Sep)
Authors
5名
Type
Case Reports, Journal Article
PubMedで原文を見る
( 02 )TRIALS / JAPAN · 0件

日本で参加できる治験

現在 募集中のもの

日本で現在募集中の治験は見つかりませんでした。下の公式レジストリで条件を変えると見つかる場合があります。
( 03 )REGISTRY / jRCT

治験をもっと探す

日本の公式レジストリで全件を確認

上の一覧は ClinicalTrials.gov の一部です。日本国内の治験の多くは、日本の公式レジストリ jRCT にのみ登録されています。下記から最新の全件をご確認ください。

※ jRCTは自動の大量データ取得を禁じているため、本サービスはjRCTを自動収集せず、患者ご自身が公式サイトで検索できるリンクでご案内しています(規約順守)。

お金・介護・制度TRPV4異常症の療養に使えるかもしれない公的サポートを調べる医療費・生活費・介護の支援制度と相談先を、あなたの状況に合わせてご案内(回答は端末内で完結)
( 04 )SUPPORT

患者会・相談窓口

一人で抱え込まないでください

同じ病気の患者・家族とつながる、制度や生活の相談をする、といったときの窓口です。

全国の相談先

※ お住まいの都道府県の「難病相談支援センター」でも、医療費助成や療養生活の相談ができます(難病情報センターから探せます)。